Lucid Diagnostics Inc.
LUCD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $113,838 | $102,506 | $47,243 |
| - Cash | $47,332 | $31,123 | $25,238 | $22,358 |
| + Debt | $1,157 | $27,553 | $35,270 | $21,254 |
| Enterprise Value | – | $110,268 | $112,538 | $46,139 |
| Revenue | $1,211,000 | $1,163 | $828 | $1,197 |
| % Growth | 104,027.3% | 40.5% | -30.8% | – |
| Gross Profit | -$486,000 | -$622 | -$723 | -$948 |
| % Margin | -40.1% | -53.5% | -87.3% | -79.2% |
| EBITDA | -$9,954,221 | -$4,211 | -$26,678 | -$11,312 |
| % Margin | -822% | -362.1% | -3,222% | -945% |
| Net Income | -$10,397,000 | -$4,439 | -$26,908 | -$11,541 |
| % Margin | -858.5% | -381.7% | -3,249.8% | -964.2% |
| EPS Diluted | -0.1 | -0.08 | -0.52 | -0.2 |
| % Growth | -25.5% | 84.7% | -160% | – |
| Operating Cash Flow | -$10,893 | -$10,549 | -$12,465 | -$9,871 |
| Capital Expenditures | -$28 | -$25 | -$93 | -$259 |
| Free Cash Flow | -$10,921 | -$10,574 | -$12,558 | -$10,130 |